ArticleCureus2025

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma.

Atsushi Takahata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.